Experian Health's State of Claims survey finds 40% of providers have at least 10% of their claims denied, and only 30% recover most of that lost revenue.
|Videos|May 16, 2023
Private equity: Physicians become investments
Author(s)Richard Payerchin, Logan Lutton
It can be a good relationship sometimes.
Advertisement
The influx of money from private equity investments can benefit a medical practice and, ultimately, patients. Jolie Apicella, JD, previously worked as an assistant United States attorney and chief of health care fraud in the Eastern District of New York. Now in private practice, in this video series she explains the current regulatory environment and what doctors and investors should consider when joining private equity with medical enterprises.
Advertisement
Related to this article
Payer enrollment rarely lines up with a new physician’s first day. A week-by-week plan helps practices avoid a revenue gap, handle pending claims and know when the schedule can safely open.
Control of Congress, 30 governorships in Medicaid work-requirement states and eight statewide health care measures were on Tuesday's ballot. Here is what each one would change for physicians and their patients.
Only 22 of the articles in a Georgetown scoping review defined health equity, a gap the lead author said could steer resources toward the most advantaged groups.
First look at APCM data: Growth, modest reach, physician turnover for Medicare’s primary care bundle
Primary Care Collaborative leads first major study of uptake of new Advanced Primary Care Management codes.
About 1 in 3 U.S. adults avoid or delay blood tests, leaving physicians without results that inform most clinical decisions. Here's how easier scheduling, less-invasive collection options and clearer results communication can help patients complete ordered testing.
The top news stories in medicine today: At least 125 health professionals are on today's ballots as California votes on a clinic spending rule; a California doctor gets 15 years for $45 million in Medicare Botox billing; Medicare's prior authorization pilot curbs targeted services.
After private equity firms bought for-profit hospices, Medicare paid $993 more per hospice encounter and stays ran 6.3 days longer, with no increase in visits.
Advertisement
Advertisement
Trending on Medical Economics
1
Why are claims being denied in 2026? 'Services not covered' now tops the list
2
What health care really costs in retirement
3
Private equity-acquired hospices had longer stays and higher Medicare spending, study finds
4
First look at APCM data: Growth, modest reach, physician turnover for Medicare’s primary care bundle
5